These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27405588)

  • 1. Combination of a third generation bisphosphonate and replication-competent adenoviruses augments the cytotoxicity on mesothelioma.
    Jiang Y; Zhong B; Kawamura K; Morinaga T; Shingyoji M; Sekine I; Tada Y; Tatsumi K; Shimada H; Hiroshima K; Tagawa M
    BMC Cancer; 2016 Jul; 16():455. PubMed ID: 27405588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zoledronic acid produces combinatory anti-tumor effects with cisplatin on mesothelioma by increasing p53 expression levels.
    Okamoto S; Jiang Y; Kawamura K; Shingyoji M; Fukamachi T; Tada Y; Takiguchi Y; Tatsumi K; Shimada H; Hiroshima K; Kobayashi H; Tagawa M
    PLoS One; 2013; 8(3):e60297. PubMed ID: 23555949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E1B-55 kDa-defective adenoviruses activate p53 in mesothelioma and enhance cytotoxicity of anticancer agents.
    Yamanaka M; Tada Y; Kawamura K; Li Q; Okamoto S; Chai K; Yokoi S; Liang M; Fukamachi T; Kobayashi H; Yamaguchi N; Kitamura A; Shimada H; Hiroshima K; Takiguchi Y; Tatsumi K; Tagawa M
    J Thorac Oncol; 2012 Dec; 7(12):1850-1857. PubMed ID: 23154556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zoledronic acid produces antitumor effects on mesothelioma through apoptosis and S-phase arrest in p53-independent and Ras prenylation-independent manners.
    Okamoto S; Kawamura K; Li Q; Yamanaka M; Yang S; Fukamachi T; Tada Y; Tatsumi K; Shimada H; Hiroshima K; Kobayashi H; Tagawa M
    J Thorac Oncol; 2012 May; 7(5):873-82. PubMed ID: 22481236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An MDM2 inhibitor achieves synergistic cytotoxic effects with adenoviruses lacking E1B55kDa gene on mesothelioma with the wild-type p53 through augmenting NFI expression.
    Nguyen TTT; Shingyoji M; Hanazono M; Zhong B; Morinaga T; Tada Y; Shimada H; Hiroshima K; Tagawa M
    Cell Death Dis; 2021 Jul; 12(7):663. PubMed ID: 34230456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of p53 synergistically augments caspases-mediated apoptosis induced by replication-competent adenoviruses in pancreatic carcinoma cells.
    Takei Y; Okamoto S; Kawamura K; Jiang Y; Morinaga T; Shingyoji M; Sekine I; Kubo S; Tada Y; Tatsumi K; Shimada H; Hiroshima K; Yamaguchi N; Tagawa M
    Cancer Gene Ther; 2015 Sep; 22(9):445-53. PubMed ID: 26251031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulated p53 expression activates apoptotic pathways in wild-type p53-bearing mesothelioma and enhances cytotoxicity of cisplatin and pemetrexed.
    Li Q; Kawamura K; Yamanaka M; Okamoto S; Yang S; Yamauchi S; Fukamachi T; Kobayashi H; Tada Y; Takiguchi Y; Tatsumi K; Shimada H; Hiroshima K; Tagawa M
    Cancer Gene Ther; 2012 Mar; 19(3):218-28. PubMed ID: 22223137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zoledronic acid, a third-generation bisphosphonate, inhibits cellular growth and induces apoptosis in oral carcinoma cell lines.
    Tamura T; Shomori K; Nakabayashi M; Fujii N; Ryoke K; Ito H
    Oncol Rep; 2011 Apr; 25(4):1139-43. PubMed ID: 21249320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic effects of replication-competent adenoviruses on human esophageal carcinoma are enhanced by forced p53 expression.
    Yang S; Kawamura K; Okamoto S; Yamauchi S; Shingyoji M; Sekine I; Kobayashi H; Tada Y; Tatsumi K; Hiroshima K; Shimada H; Tagawa M
    BMC Cancer; 2015 Jun; 15():464. PubMed ID: 26059686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxicity of replication-competent adenoviruses powered by an exogenous regulatory region is not linearly correlated with the viral infectivity/gene expression or with the E1A-activating ability but is associated with the p53 genotypes.
    Yamauchi S; Zhong B; Kawamura K; Yang S; Kubo S; Shingyoji M; Sekine I; Tada Y; Tatsumi K; Shimada H; Hiroshima K; Tagawa M
    BMC Cancer; 2017 Sep; 17(1):622. PubMed ID: 28874135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin produces growth inhibitory effects in combination with nutlin-3a on malignant mesothelioma through a cross-talk between mTOR and p53 pathways.
    Shimazu K; Tada Y; Morinaga T; Shingyoji M; Sekine I; Shimada H; Hiroshima K; Namiki T; Tatsumi K; Tagawa M
    BMC Cancer; 2017 May; 17(1):309. PubMed ID: 28464864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combinatory cytotoxic effects produced by E1B-55kDa-deleted adenoviruses and chemotherapeutic agents are dependent on the agents in esophageal carcinoma.
    Ma G; Kawamura K; Li Q; Okamoto S; Suzuki N; Kobayashi H; Liang M; Tada Y; Tatsumi K; Hiroshima K; Shimada H; Tagawa M
    Cancer Gene Ther; 2010 Nov; 17(11):803-13. PubMed ID: 20689571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replication-competent adenoviruses with the type 35-derived fiber-knob region achieve reactive oxygen species-dependent cytotoxicity and produce greater toxicity than those with the type 5-derived region in pancreatic carcinoma.
    Yamauchi S; Kawamura K; Okamoto S; Morinaga T; Jiang Y; Shingyoji M; Sekine I; Kubo S; Tada Y; Tatsumi K; Shimada H; Hiroshima K; Tagawa M
    Apoptosis; 2015 Dec; 20(12):1587-98. PubMed ID: 26373551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of a p53-activating CP-31398 and an MDM2 or a FAK inhibitor produces growth suppressive effects in mesothelioma with wild-type p53 genotype.
    Zhong B; Shingyoji M; Hanazono M; Nguyễn TT; Morinaga T; Tada Y; Shimada H; Hiroshima K; Tagawa M
    Apoptosis; 2020 Aug; 25(7-8):535-547. PubMed ID: 32468177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zoledronic acid activates the DNA S-phase checkpoint and induces osteosarcoma cell death characterized by apoptosis-inducing factor and endonuclease-G translocation independently of p53 and retinoblastoma status.
    Ory B; Blanchard F; Battaglia S; Gouin F; Rédini F; Heymann D
    Mol Pharmacol; 2007 Jan; 71(1):333-43. PubMed ID: 17050806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53-independent anti-tumor effects of the nitrogen-containing bisphosphonate zoledronic acid.
    Kuroda J; Kimura S; Segawa H; Sato K; Matsumoto S; Nogawa M; Yuasa T; Kobayashi Y; Yoshikawa T; Ottmann OG; Maekawa T
    Cancer Sci; 2004 Feb; 95(2):186-92. PubMed ID: 14965371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An image cytometric technique is a concise method to detect adenoviruses and host cell proteins and to monitor the infection and cellular responses induced.
    Morinaga T; Nguyễn TTT; Zhong B; Hanazono M; Shingyoji M; Sekine I; Tada Y; Tatsumi K; Shimada H; Hiroshima K; Tagawa M
    Virol J; 2017 Nov; 14(1):219. PubMed ID: 29126418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zoledronic acid inhibits proliferation of human fibrosarcoma cells with induction of apoptosis, and shows combined effects with other anticancer agents.
    Koto K; Murata H; Kimura S; Horie N; Matsui T; Nishigaki Y; Ryu K; Sakabe T; Itoi M; Ashihara E; Maekawa T; Fushiki S; Kubo T
    Oncol Rep; 2010 Jul; 24(1):233-9. PubMed ID: 20514467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A monomer purified from Paris polyphylla (PP-22) triggers S and G2/M phase arrest and apoptosis in human tongue squamous cell carcinoma SCC-15 by activating the p38/cdc25/cdc2 and caspase 8/caspase 3 pathways.
    Ke JY; Zhang W; Gong RS; Cen WJ; Huang HQ; Li YR; Kong WD; Jiang JW
    Tumour Biol; 2016 Nov; 37(11):14863-14872. PubMed ID: 27644244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovirus-mediated p14(ARF) gene transfer in human mesothelioma cells.
    Yang CT; You L; Yeh CC; Chang JW; Zhang F; McCormick F; Jablons DM
    J Natl Cancer Inst; 2000 Apr; 92(8):636-41. PubMed ID: 10772681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.